Yield10 Bioscience logo
Yield10 Bioscience YTEN
$ 5.87 15.32%

Quarterly report 2024-Q2
added 08-14-2024

report update icon

Yield10 Bioscience Financial Ratios 2011-2024 | YTEN

Annual Financial Ratios Yield10 Bioscience

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.2 -1.0 -1.6 -4.9 -0.2 -1.1 -0.7 -1.4 -0.9 -0.9 -1.6 14.3 -2.1

P/S

50.3 29.4 28.1 62.1 2.9 18.0 6.7 8.9 8.3 9.0 9.1 1.2 57.5

EPS

-1.8 -2.8 -2.3 -4.3 -35.5 -0.9 -3.3 -2.7 -0.9 -2.9 -5.3 0.1 -1.2

EV (Enterprise Value)

8.34 M 14.5 M 16.3 M 51.2 M 17.8 M 9.49 M -4.79 M 7.36 M 13.3 M 9.49 M 47.6 M 43.6 M 104 M

EBITDA per Share

-1.78 -2.68 -2.42 -2.83 -23 -36.6 -110 -140 -376 -1.03 K -2.06 K 344 -2.87 K

EV/EBITDA

-1.2 -5.2 0.4 -0.8 0.9 -0.3 -0.4 -0.2 -1.4 7.6 -1.6

PEG

0.01 0.02 0.03 -0.06 -0.05 -0.02 0.03 -0.02 -0.01 -0.02 0.0 0.13 -0.15

P/B

-1.2 3.0 1.1 5.2 -0.6 1.8 0.5 1.6 1.7 1.3 2.4 1.1 2.1

P/CF

-0.3 -1.2 -1.9 -5.7 -0.3 -1.1 -0.8 -0.7 -1.0 -1.0 -1.8 -1.6 -2.5

ROE %

582.16 -308.32 -68.83 -107.07 317.16 -160.51 -69.59 -119.39 -181.77 -157.13 -149.55 7.67 -98.28

ROA %

-369.98 -167.79 -54.03 -70.28 -77.50 -111.91 -55.66 -70.75 -138.58 -127.66 -114.09 6.78 -46.78

ROCE %

580.63 -305.70 -72.96 -75.61 -59.24 -139.50 -63.99 -128.26 -180.17 -141.61 -148.48 7.58 -51.30

Current Ratio

0.6 2.2 4.7 5.7 5.3 4.1 6.3 2.8 3.8 5.2 4.1 8.2 10.9

DSO

- 66.5 74.3 51.6 41.7 105.0 46.0 59.2 75.1 75.2 83.6 11.1 194.9

DIO

- - - - - - - - 209.6 144.3 491.4 820.1 -

DPO

- - - - - - - - 66.4 82.0 69.8 315.6 7.6

Operating Cycle

- 66.5 74.3 - - - - - 284.7 219.5 575.0 831.2 194.9

Cash Conversion Cycle

- 66.5 74.3 - - - - - 218.4 137.5 505.1 515.6 187.3

All numbers in USD currency

Quarterly Financial Ratios Yield10 Bioscience

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-5.04 -4.77 - -0.41 -15.42 -18.16 - -0.71 -0.7 -0.68 - -0.49 -0.64 -0.6 - -0.87 -0.92 -2.12 - -6.33 -5.99 -8.61 - -0.26 -0.24 -0.92 - -0.59 -0.96 -0.74 - 1.44 -1.15 -0.24 -0.22 -0.22 -0.26 -0.26 -0.31 -0.84 -0.21 -0.23 -0.24 -0.21 -0.23 -0.2 -0.28 -0.23 -0.23 0.84 -0.28 -0.28 -0.33 -0.36

EBITDA per Share

- -4.58 - - - -17.9 - -0.67 -0.68 -0.67 - -0.6 -0.61 -0.58 - -0.83 -1.04 -1.54 - -5.91 -5.76 -8.51 - -0.25 -0.23 -0.23 - -0.53 -0.91 -0.71 - -0.77 -0.81 -0.13 -0.22 -0.11 -0.26 -0.26 -0.26 -0.67 -0.18 -0.21 -0.23 -0.17 -0.2 -0.19 -0.28 -0.2 -0.21 0.86 -0.28 -0.25 -0.31 -0.34

ROE %

-1774.50 -2453.49 -1908.48 -1956.80 -1054.62 -461.05 -107.06 -120.03 -84.68 -66.27 -39.17 -61.92 -71.69 -75.42 -79.35 -30.83 40.43 105.07 149.65 103.35 8.53 -79.27 -128.52 -143.52 -112.22 -90.42 -50.69 12.49 90.67 60.66 -89.06 -134.47 -242.54 -238.95 -181.77 -169.61 -166.72 -158.60 -157.13 -166.16 -159.71 -159.79 -149.56 -127.37 -108.18 -86.41 7.67 3.44 -4.43 -12.93 -98.28 -24.23 -25.29 -24.43

ROA %

-290.69 -244.31 -195.28 -226.23 -195.52 -156.93 -74.55 -85.00 -64.50 -52.64 -32.01 -46.93 -51.41 -51.52 -52.09 -63.94 -60.87 -59.69 -36.57 -56.92 -65.42 -72.69 -56.50 -68.50 -60.14 -57.83 -40.54 -3.10 46.33 32.73 -52.77 -87.40 -159.06 -164.85 -138.58 -130.98 -130.87 -126.61 -127.66 -132.90 -125.90 -124.05 -114.10 -99.62 -86.97 -72.41 6.78 12.99 15.93 18.74 -46.78 -11.53 -12.04 -11.63

ROCE %

-1764.29 -2440.34 -1901.80 -1950.14 -1053.84 -462.59 -106.93 -123.65 -92.03 -73.63 -42.83 -65.84 -72.14 -79.50 -73.43 -24.52 47.41 116.29 151.31 104.35 8.47 -80.66 -130.29 -144.97 -112.69 -90.10 -50.02 -90.91 -117.11 -136.41 -135.89 -181.31 -164.27 -171.93 -161.05 -146.53 -158.38 -147.31 -142.41 -150.58 -146.74 -146.79 -139.94 -120.99 -105.49 -86.27 7.61 3.35 -4.57 -13.11 -98.47 -24.27 -25.35 -24.48

Current Ratio

0.3 0.6 0.6 1.1 1.1 1.3 2.2 2.8 3.6 4.4 4.7 5.2 5.3 6.2 2.9 2.9 2.9 2.9 0.8 0.8 0.8 0.8 1.8 1.8 1.8 1.8 5.0 5.0 5.0 5.0 2.5 2.5 2.5 2.5 4.2 4.2 4.2 4.2 5.3 5.3 5.3 5.3 4.2 4.2 4.2 4.2 8.7 8.7 8.7 8.7 1.9 1.9 1.9 1.9

DSO

- - - - - - - 29.6 70.4 88.2 - 49.6 30.1 29.1 - 38.5 35.5 40.3 - 29.3 20.7 61.1 - 112.9 30.1 112.5 - 22.1 16.8 16.9 - 12.7 32.0 88.3 43.8 66.4 29.2 20.0 4.8 6.5 5.9 77.6 122.0 144.6 53.3 43.1 54.8 113.6 83.0 1.1 30.4 28.4 69.8 -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

- - - - - - - 29.6 70.4 88.2 - 49.6 30.1 29.1 - 38.5 35.5 40.3 - 29.3 20.7 61.1 - 112.9 30.1 112.5 - 22.1 16.8 16.9 - 12.7 32.0 88.3 43.8 66.4 29.2 20.0 4.8 6.5 5.9 77.6 122.0 144.6 53.3 43.1 54.8 113.6 83.0 1.1 30.4 28.4 69.8 -

Cash Conversion Cycle

- - - - - - - 29.6 70.4 88.2 - 49.6 30.1 29.1 - 38.5 35.5 40.3 - 29.3 20.7 61.1 - 112.9 30.1 112.5 - 22.1 16.8 16.9 - 12.7 32.0 88.3 43.8 66.4 29.2 20.0 4.8 6.5 5.9 77.6 122.0 144.6 53.3 43.1 54.8 113.6 83.0 1.1 30.4 28.4 69.8 -

All numbers in USD currency